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Abstract
Background—Observational studies of preventive medications, such as vaccinations, can suffer 
from the healthy-user bias because vaccinated patients may be healthier than unvaccinated 
patients. Indicators of health status and frailty suitable for attenuating this bias could be identified 
in administrative data.
Objective—To examine the association of baseline variables and time-dependent hospitalization 
and skilled nursing care with the receipt of influenza vaccination in patients with end-stage renal 
disease.
Research Design—Observational cohort study using United States Renal Data System files 
each year from 1999 to 2005.
Subjects—Population-based cohorts that included >115,000 adult, hemodialysis patients each 
year.
Measures—We estimated hazard ratios for the association of baseline variables and time-
dependent hospitalization days and skilled nursing days with influenza vaccination, controlling for 
demographic and baseline health status variables.
Results—Vaccination coverage increased from 47% in 1999 to 60% in 2005. Patients with any 
length of hospitalization were less likely to be vaccinated, however, the association was stronger in 
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patients with longer stays [15–25 d: hazard ratio = 0.64 (95% confidence interval, 0.62–0.65); 26–
30 d: 0.40 (0.38–0.42)]. Patients with any length of skilled nursing care of >1 day had similar 
estimates; these patients were also less likely to be vaccinated [26–30 d: 0.66 (0.64–0.69)].
Conclusions—Patients with long hospitalizations or skilled nursing stays were less likely to be 
vaccinated suggesting evidence of the healthy-user effect. These variables could be used to 
account for bias in studies of preventive services in patients on dialysis.
Keywords
influenza vaccines; bias (epidemiology); confounding factors (epidemiology); renal dialysis; 
cohort studies
Patients who receive prevention health care, such as preventive medications, screening tests, 
and vaccinations, have been shown to be in overall better health and more likely to engage in 
other healthy behaviors.1,2 This situation has the potential to exaggerate the benefits of the 
intervention under study, resulting in what is called the healthy-user bias.3 The healthy-user 
bias has been suspected in studies of preventive medications such as hormone replacement 
therapy and cardiovascular disease,4 and with statin therapy and several disease 
outcomes.5–7 Alternatively, it has been suggested in influenza vaccine effectiveness studies 
where patients who are not vaccinated had a lower functional status.8 It appears to be 
difficult to adequately control for this bias using typical health care (eg, claims) data.
Yearly, inactivated influenza vaccination is recommended for patients with end-stage renal 
disease (ESRD) by the Advisory Committee on Immunization Practices; however, few 
studies have described who gets the vaccine each year, or if the vaccinated population has 
underlying characteristics that predispose them to have better health outcomes. ESRD 
patients are at a particularly high risk of hospitalization, due to an increased risk of infection 
and cardiovascular disease, as well as a high prevalence of comorbidities (eg, diabetes). It 
has been shown that preventive medications and vaccinations are less likely to be 
administered to patients near death,9,10 and thus hospitalization and skilled nursing care are 
of particular interest as both can be identified easily in health care claims data. 
Understanding who is vaccinated can better elucidate characteristics that differ between the 
vaccinated and unvaccinated populations that must be taken into account in studies of 
vaccine effectiveness (ie, confounding variables).
This study aimed to describe the vaccinated population of patients on hemodialysis to 
identify variables implicated in the healthy-user effect. We assessed demographic and health 
status variables and investigated how hospitalization and skilled nursing care were related to 
vaccination. We hypothesized that people with many hospital days or skilled nursing days 
each month would be less likely to be vaccinated, suggesting that time-varying measures of 
hospitalization and skilled nursing care may be a way of accounting for the healthy-user bias 
in administrative claims data.
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We used Medicare claims obtained from the United States Renal Data System. The United 
States Renal Data System is a population-based, national system that collects information on 
all patients with ESRD in the United States. Detailed health claims are captured for all 
patients with Medicare as a primary payer status (ie, we excluded patients covered by a 
health maintenance organization or Medicare as a secondary payer). Information collected 
includes physician services, International Classification of Diseases, 9th rev., Clinical 
Modification (ICD-9-CM) codes assigned to hospitalizations and outpatient care, 
information on routine dialysis care, and immunization use.
Yearly cohorts were created for each influenza season from 1999 to 2005. To limit outcome 
misclassification, we used those years in which influenza vaccine was not easily obtained in 
the community, such as grocery stores and pharmacies. Our cohorts consisted of all adult, 
ESRD patients with Medicare as a primary payer and continuous hemodialysis use when 
follow-up began on September 1 of each year. Each yearly cohort consisted of patients who 
had initiated dialysis before October 1 of the preceding year. An 8-month window from 
January 1 to August 31 before the start of follow-up of each year was used to identify 
insurance status and comorbidities for the patients in that cohort. Patients were required to 
be on continuous hemodialysis for 3 months before the start of follow-up (see online figure, 
Supplemental Digital Content 1, http://links.lww.com/MLR/A545). For example, the cohort 
identified for the 1999 season would have initiated dialysis before October 1, 1998 and 
would have had Medicare as a primary payer from January 1 to August 31, 1999 and used 
continuous hemodialysis from June 1 to August 31. Hospital days, skilled nursing days, and 
vaccination status were assessed beginning on September 1 of each year. We performed an 
analysis of time to vaccination where cohort members were followed each year until they 
experienced a vaccination event, death, kidney transplant, loss-to-follow-up, or 
administrative censoring on December 31 of that year, whichever came first.
Hospitalization, Skilled Nursing Care, and Vaccination Status
Hospitalization and skilled nursing facility admission and discharge dates were assessed 
using the Part A—Hospitalization Medicare claims.
To identify influenza vaccinations, Medicare Part A hospital/outpatient files and Part B 
physician/supplier files were searched for Current Procedural Terminology codes 90724, 
90656, 90658-60, the HCFA Common Procedure Coding System codes G0008 and G8482, 
and the ICD-9-CM procedure code 99.52.
Time-fixed Covariates
Time-fixed covariates were assessed to determine their effect on vaccination. The Centers 
for Medicare and Medicaid Services form 2827, the Medical Evidence Form, was used to 
ascertain age, race, sex, first service date with ESRD, and cause of kidney failure. The first 
service date was used to calculate vintage—the length of time with ESRD as of September 1 
of each year. The 8-month window from January 1 to August 31 was searched for the 
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following co-morbidities in both Part A and Part B claims as identified in Liu et al11: 
ischemic heart disease, congestive heart failure, cerebrovascular accident/transient ischemic 
attack, peripheral vascular disease, other cardiac disease, chronic obstructive pulmonary 
disease, gastrointestinal bleeding, liver disease, dysrhythmia, cancer, and diabetes. 
Comorbidities were modeled as individual dichotomous variables in the final models. 
Adherence to dialysis was calculated using the sum of the number of dialysis sessions over 
the 8-month baseline period: patients were considered adherent if they had ≥ 95 sessions, 
which is approximately 3 sessions a week (the standard dialysis regimen) over 8 months. 
Patients with no recorded dialysis sessions over the 8-month period were dropped from the 
analysis. We also included the number of hospital days over the baseline period and 
controlled for an ad-hoc selection of potential frailty markers including oxygen use and use 
of mobility aids. Use of mobility aids were ascertained by searching Part A and Part B 
claims for HCFA Common Procedure Coding System equipment codes for wheelchairs, 
walkers, canes, and assisted bathroom equipment during the baseline period (see online 
table, Supplemental Digital Content 2, http://links.lww.com/MLR/A546).
Statistical Analysis
For time-fixed covariates, we used 1 Cox proportional hazards model to estimate hazard 
ratios (HRs)12 comparing baseline characteristics with vaccination status. Proportional 
hazards were assessed by interacting each covariate with time.
For time-dependent covariates, we used 2, separate pooled logistic models with days as a 
time scale, which estimate discrete-time approximations13 of cause-specific HRs12 by 
comparing patients with hospital and skilled nursing days to patients without these 
exposures. For each exposure, we counted the number of hospital or skilled nursing days the 
patient had in the prior 30 days and we fit the models by categorizing the exposures into 
temporary (1 d), short (2–3 d), medium (4–14 d), medium-long (15–25 d), and long stays 
(26–30 d). We controlled for age at the start of follow-up, race, sex, cause of ESRD, vintage, 
adherence to dialysis, number of mobility aids, ESRD network, baseline oxygen use, total 
baseline hospital days, and comorbidities in all analyses. Continuous variables entered 
models assuming a log-linear association with vaccination.
To evaluate the impact of these time-dependent variables, we performed a sensitivity 
analysis to estimate vaccine effectiveness on mortality after adjusting for hospitalization and 
skilled nursing care. We made the following assumptions for this analysis: (1) the 
hypothetical cohort consisted of 100,000 people; (2) the crude vaccine effectiveness was 
25%14,15; (3) 50% of patients were vaccinated; (4) patients who were hospitalized or had 
skilled nursing care were more likely to die; and (5) there was odds ratio heterogeneity 
between strata of confounders (ie, the association between confounder and death would vary 
by the number of days). We included 3 scenarios, where we varied the strength of the 
association between the confounders and death (denoted Odds RatioConfounder) from 1.1 to 
10.0, stratified by the number of days. Bias adjustment was carried out using the method 
outlined in Rothman et al16 (p. 350). Briefly, for each strata of hospitalization or skilled 
nursing care, we calculated the adjusted cell counts using the naive person counts, Odds 
RatioConfounder, and stratum-specific vaccination prevalence estimated from the study data. 
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Next, we calculated the stratum-specific odds ratios for the association between vaccination 
and death. Finally, we combined the bias-adjusted, stratum-specific odd ratios using the 
Mantel-Haenszel method to produce the overall, adjusted effect estimate (denoted Odds 
RatioVaccination). Analyses were conducted using SAS 9.2 (Cary, NC), using Efron’s method 
for tied event times.17 This study was determined to be exempt from full review by the 
Institutional Review Board at the University of North Carolina at Chapel Hill.
RESULTS
There were >100,000 patients in the cohort for each year. Vaccination coverage increased 
from 47% to 60% over the study years. Whites had higher coverage than blacks and this 
difference increased throughout the study period (Table 1). In years when there was no 
vaccine shortage, ~75% of vaccine doses were administered by the end of October. In the 
2000, 2001, and 2004 seasons most doses were not given until November; however, on 
average 99% of doses were given by the end of December (Fig. 1).
In the multivariable Cox proportional hazard models adjusting for time-fixed covariates, 
blacks and other races were less likely to be vaccinated, as well as patients with >5-day 
hospital stay during the baseline period. Patients on dialysis for ≥ 10 years were generally 
less likely to be vaccinated, although this was a small group and thus the estimates were 
imprecise. Older patients and patients with a high level of dialysis adherence were more 
likely to be vaccinated (Table 2). Most comorbidities did not strongly predict vaccination 
status (Table 3). These differences persisted throughout the study period.
The pooled crude vaccination rate was lowest for patients with 26–30 hospital days 
(2.6/1000 person-days) and for patients with 4–14 skilled nursing days (4.4/1000 person-
days) (Table 4). Patients with any length of hospital stay were less likely to be vaccinated, 
however, the association was stronger in patients with longer stays [15–25 d: HR = 0.64 
(95% CI, 0.62–0.65); 26–30 d: 0.40 (0.38, −0.42)], suggesting that recently hospitalized 
patients were much less likely to be vaccinated than those not in the hospital (Table 5). The 
estimates were similar for patients with any length of skilled nursing care stay of >1 day; 
these patients were also less likely to be vaccinated [26–30 d: 0.66 (0.64–0.69)]. However, 
we found only a weak effect for patients with 1 day of skilled nursing care [0.95 (0.86–
1.04)] (Table 5). Estimates from the bias analysis implemented within a hypothetical cohort 
suggest that adjusting for hospitalization or skilled nursing care would weaken the vaccine 
effect on mortality (Table 6). For example, when adjusting for hospitalization using the more 
conservative confounder-disease associations from scenario 1, the odds ratio between 
vaccination and death moved from 0.75 to 0.83. When using more extreme confounder-
disease associations in scenarios 2 and 3 the adjusted estimates moved closer to the null. The 
same trend was observed when adjusting for skilled nursing care.
DISCUSSION
In this population-based study of high-risk patients with ESRD, we found that patients with 
a recent, long-term hospital or skilled nursing facility stay were much less likely to receive 
an influenza vaccination. The strength of the association for long-term stays for both 
McGrath et al. Page 5













variables was similar each influenza season during the 7-year study period. Elective 
hospitalizations were most likely represented by short stays. Patients with stays of 2–3 
hospital days were most similar to those with no hospitalizations, indicating that perhaps 
physicians were less likely to have time to provide vaccination for those with a stay of only 
1 day, and less likely to vaccinate if the patient was sick enough to require a longer stay. 
Patients with only 1 day of skilled nursing care were similarly likely to be vaccinated 
compared with patients with no skilled nursing care. The reasons for requiring skilled 
nursing care for only 1 day are unclear, but it may indicate an additional encounter with the 
health care system or that these patients were not very ill.
In a study based on medical record review, Jackson et al8 also found that patients with poor 
functional status are less likely to be vaccinated. They found that adjusting for variables such 
as dementia, assistance bathing, assistance ambulating, and living in a nonhome setting 
reduced the amount of bias present in estimates of vaccine effectiveness. These variables, 
however, are generally not present in administrative claims data and therefore vaccine 
effectiveness studies that adjust for frailty have been limited to small studies using chart 
review. In fact, we attempted to include variables that could be proxies for functional status
—use of mobility aids and home oxygen use; however, people with these conditions were 
slightly more likely to be vaccinated. Although the effect was not strong, it is likely that 
functional status may be quantified differently in patients on dialysis, as they are being seen 
3 times per week regardless of their mobility or oxygen status. However, we did find similar 
strength of associations for vaccination status as Jackson’s functional status variables, by 
using recent hospitalization or skilled nursing care in a time-varying manner, which may be 
more applicable in characterizing health status in this population. In addition, our bias 
analysis suggests that the estimate of vaccine effectiveness on mortality would move toward 
the null upon adjustment for hospitalization and skilled nursing care, similar to what Jackson 
found when adjusting for functional status.
It is possible that patients got vaccinated during their hospital stay without the hospital 
billing Medicare for the influenza vaccine, which provides an alternative explanation for the 
monotonic decline in vaccination rates with increasing number of hospital days above 1 day. 
However, data from the hospital discharge summaries from Healthcare Cost and Utilization 
Project indicate that hospitals rarely gave influenza vaccinations until 2004, when 
vaccinations began to increase.18 This failure to offer influenza vaccine to hospitalized 
patients has recently been resolved—as of January 2012, the Centers for Medicare and 
Medicaid Services requires that all persons over the age of 6 months who are hospitalized be 
offered the influenza vaccine if discharged during the influenza season. Although studies 
using recent data would need to take this into account, we do not think that the vaccination 
rate in the hospital was high enough during our study period to fully explain the results 
observed.
Often in studies using administrative claims, the presence of comorbidities are used to 
characterize the health status of each patient. Although we used algorithms for co-
morbidities that were developed within the population with ESRD, we found most 
comorbidities were not strongly associated with vaccination status, indicating that using 
these variables may not adequately capture the healthy-user effect. In fact, adjustment for 
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comorbidities in a study estimating influenza vaccine effectiveness resulted in a more biased 
estimate in the presence of strong unmeasured confounding.8 Although different definitions 
that attempt to include disease severity may perform slightly better in controlling the 
healthy-user bias in the elderly population,8 we found little difference in the associations 
with vaccination in the renal population. In addition, most comorbidities are assessed over a 
period at baseline (8 mo in our study). Therefore, having a claim for an illness at baseline 
would not capture acute illness, which may be a better proxy of severe frailty. Finally, it has 
been suggested that using ICD-9-CM comorbidity codes from administrative data may lack 
the sensitivity for identifying these illnesses, which can result in substantial residual 
confounding.19,20
We found persistent demographic disparities in those who received the vaccine each year. 
African Americans and other races consistently were less likely to be vaccinated. This 
disparity has been documented in the dialysis population,14 adults with high-risk 
conditions,21 and the general Medicare population.22 Explanations for this difference 
include varying rates of provider recommendations and fear of getting sick/side effects from 
the vaccine.23
There were 2 additional time-fixed variables that could potentially be variables to adjust for 
healthy-user bias in vaccine effectiveness studies. Patients who were more adherent to their 
dialysis regimens were more likely to be vaccinated, whereas patients with a long vintage, 
and who are presumably sicker were less likely to be vaccinated. If these variables were left 
unadjusted, both would make the vaccine look more protective in studies of vaccine 
effectiveness. In comparison, age is an indicator of confounding by indication. During the 
years of our study, the indications for administering influenza vaccine were partially age 
based—the elderly were recommended to receive the vaccine. Our results paralleled this 
age-based recommendation where the oldest age group was more likely to be vaccinated.
Our study may have been subjected to some outcome misclassification. As with any study 
on influenza vaccination, it is possible that patients could have obtained the vaccine from a 
nonmedical establishment and paid out-of-pocket. In this case, there would not be a 
Medicare claim for vaccination and we could not have determined that they were vaccinated. 
There have been few studies that have estimated vaccination rates using data other than 
Medicare billing claims. Two studies have surveyed dialysis networks and estimated 
influenza vaccination coverage to be 74% and 76% in 1998 and 2005, respectively.24,25 
However, self-reported influenza vaccination that was administered outside of the dialysis 
clinics was not validated. In addition, the studies did not report the percentage of patients 
who were vaccinated outside the dialysis clinic; therefore, it is difficult to use these 
estimates as a gold standard. To limit outcome misclassification, we chose to examine years 
before the popularization of obtaining vaccine in groceries and pharmacies, although the 
later years in our study may have been affected by this trend. In addition, because influenza 
vaccine is covered by Medicare for our study population and patients on dialysis usually 
have health care encounters 2–3 times per week, we expect that the number of people who 
paid out-of-pocket would be low.
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In summary, this analysis suggests that patients with a recent, long-term hospitalization or 
skilled nursing facility stay were much less likely to undergo the preventive health measure 
of influenza vaccination. Further work on understanding how these variables could be used 
to control the healthy-user bias in effectiveness studies of preventive medications is needed.
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Refer to Web version on PubMed Central for supplementary material.
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Cumulative, administered influenza vaccine doses by month and year. *Normal year is 
defined as the average of 1999, 2002, 2003, and 2005.
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TABLE 4
Pooled, Crude Vaccination Rate by Categories of Hospital and Skilled Nursing Days
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